Recursos y estrategias para optimizar el manejo de los pacientes con artritis psoriásica: proyecto CREA

Torre Alonso, 1991, Psoriatic arthritis (PA): A clinical, immunological and radiological study of 180 patients, Br J Rheumatol, 30, 245, 10.1093/rheumatology/30.4.245 Veale, 2018, The pathogenesis of psoriatic arthritis, Lancet, 391, 2273, 10.1016/S0140-6736(18)30830-4 Pérez, 2020, Higher prevalence of psoriatic arthritis in the adult population in Spain? A population-based cross-sectional study, PLoS One, 15, 1 Coates, 2021, GRAPPA Treatment Recommendations: An Update From the 2020 GRAPPA Annual Meeting, J Rheumatol Suppl, 97, 65 Gottlieb, 2021, Axial psoriatic arthritis: An update for dermatologists, J Am Acad Dermatol, 84, 92, 10.1016/j.jaad.2020.05.089 Kishimoto, 2021, Clinical features of psoriatic arthritis, Best Pract Res Clin Rheumatol, 35, 101670, 10.1016/j.berh.2021.101670 Radner, 2017, Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis Psoriasis, or Psoriatic Arthritis, Arthritis Care Res (Hoboken), 69, 1510, 10.1002/acr.23171 Husted, 2001, Health-Related Quality of Life of Patients With Psoriatic Arthritis: A Comparison With Patients With Rheumatoid Arthritis, Arthritis Rheum, 45, 151, 10.1002/1529-0131(200104)45:2<151::AID-ANR168>3.0.CO;2-T Fernández-Carballido, 2020, Impact of Comorbidity on Physical Function in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics: Results From a Cross-Sectional Study, Arthritis Care Res (Hoboken), 72, 822, 10.1002/acr.23910 Gossec, 2020, et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Ann Rheum Dis, 79, S700 Torre Alonso, 2018, Recomendaciones de la Sociedad Española de Reumatología sobre el tratamiento y uso de terapias sistémicas biológicas y no biológicas en artritis psoriásica, Reumatol Clin, 14, 254, 10.1016/j.reuma.2017.08.007 Gratacós, 2021, A 12-point recommendation framework to support advancement of the multidisciplinary care of psoriatic arthritis: A call to action, J Bone Spine, 88, 105175, 10.1016/j.jbspin.2021.105175 Gratacós, 2018, Standards of care and quality indicators for multidisciplinary care models for psoriatic arthritis in Spain, Rheumatol Int, 38, 1115, 10.1007/s00296-018-3986-4 Queiro, 2020, Estado actual de la atención multidisciplinar para pacientes con artritis psoriásica en España: proyecto NEXUS 2.0, Reumatol Clin, 16, 24, 10.1016/j.reuma.2018.01.010 García, 2020, Evaluating standards of care in psoriatic arthritis of the QUANTUM project (qualitative initiative to improve outcomes): Results of an accreditation project in Spain, Rheumatol Int, 40, 1817, 10.1007/s00296-020-04632-2 Almodóvar, 2021, Definition of Remission and Disease Activity Assessment in Psoriatic Arthritis: Evidence and Expert-Based Recommendations, Reumatol Clin, 17, 343, 10.1016/j.reuma.2019.10.003 Cañete, 2020, Expert consensus on a set of outcomes to assess the effectiveness of biologic treatment in psoriatic arthritis: The mereces study, J Rheumatol, 47, 1637, 10.3899/jrheum.191056 Helliwell, 2014, Qualifying Unmet Needs and Improving Standards of Care in Psoriatic Arthritis, Arthritis Care Res (Hoboken), 66, 1759, 10.1002/acr.22404 Muñoz-Fernández, 2016, Evaluation of the impact of nursing clinics in the rheumatology services, Rheumatol Int, 36, 1309, 10.1007/s00296-016-3518-z Muñoz-Fernández, 2017, SCORE study: Quality indicators for rheumatology nursing clinics, Rheumatol Int, 37, 353, 10.1007/s00296-016-3644-7 Torre-Alonso, 2017, Identification and management of comorbidity in psoriatic arthritis: Evidence- and expert-based recommendations from a multidisciplinary panel from Spain, Rheumatol Int 2017 378, 37, 1239 Queiro, 2017, Modelos de atención multidisciplinar en pacientes con artritis psoriásica en España, Reumatol Clin, 13, 85, 10.1016/j.reuma.2016.03.005 Belinchón, 2020, El papel del dermatólogo en el diagnóstico precoz de la artritis psoriásica: recomendaciones de un grupo de expertos, Actas Dermosifiliogr, 111, 835, 10.1016/j.ad.2020.06.004 Casals-Sánchez, 2012, Características de los pacientes con espondiloartritis seguidos en unidades de reumatología en España. Estudio emAR II, Reumatol Clin., 8, 107 Queiro, 2019, Very low disease activity DAPSA remission, and impact of disease in a Spanish population with psoriatic arthritis, J Rheumatol, 46, 710, 10.3899/jrheum.180460 Pardo, 2020, Disease activity in psoriatic arthritis index and psoriatic arthritis impact of disease questionnaire: Correlation and sensitivity to change in a real clinical setting, Clin Exp Rheumatol, 38, 973 Gossec, 2014, A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: laboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative, Ann Rheum Dis, 73, 1012, 10.1136/annrheumdis-2014-205207 Nolla, 2016, Estándares de calidad asistencial para las consultas externas de reumatología. El proyecto EXTRELLA, Reumatol Clin, 12, 248, 10.1016/j.reuma.2015.11.004 McGagh, 2020, Assessment of the many faces of PsA: single and composite measures in PsA clinical trials, Rheumatology, 59, i29, 10.1093/rheumatology/kez305 Najm, 2019, EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases, RMD Open, 5, e001014, 10.1136/rmdopen-2019-001014